Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease

Pharmacology Biochemistry and Behavior

Volumn 130, Issue , 2015, Pages 15-21

  Esmaeili Tazangi, Parisa ^a   Moosavi, Seyed Mostafa Shid ^a   Shabani, Mohamad ^b   Haghani, Masoud ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer's disease; Beta amyloid; Erythropoietin; Long term potentiation; Paired pulse ratio

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ERYTHROPOIETIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); GLUTAMIC ACID; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; COMPARATIVE STUDY; CONTROLLED STUDY; EXCITABILITY; FOOTSHOCK; HEMATOCRIT; HIPPOCAMPUS; LATENT PERIOD; LONG TERM POTENTIATION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL PERFORMANCE; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SURGICAL STRESS; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; MEMORY DISORDERS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; HEMATOCRIT; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MEMORY DISORDERS; NEURONAL PLASTICITY; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS;

EID: 84920901668     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.12.011     Document Type: Article

References (41)

1. B. Adamcio, D. Sargin, A. Stradomska, L. Medrihan, C. Gertler, and F. Theis Erythropoietin enhances hippocampal long-term potentiation and memory BMC Biol 6 2008 37
2. I. Aghaei, M. Shabani, N. Doustar, M. Nazeri, and A. Dehpour Peroxisome proliferator-activated receptor-gamma activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis Pharmacol Biochem Behav 120 2014 133 139
3. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 6407 1993 31 39
4. Q.S. Chen, B.L. Kagan, Y. Hirakura, and C.W. Xie Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides J Neurosci Res 60 1 2000 65 72
5. Y.H. Chung, S.I. Kim, K.M. Joo, Y.S. Kim, W.B. Lee, and K.W. Yun Age-related changes in erythropoietin immunoreactivity in the cerebral cortex and hippocampus of rats Brain Res 1018 1 2004 141 146
6. W.K. Cullen, Y.H. Suh, R. Anwyl, and M.J. Rowan Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments Neuroreport 8 15 1997 3213 3217
7. D. Debanne, N.C. Guerineau, B.H. Gahwiler, and S.M. Thompson Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release J Physiol 491 Pt 1 1996 163 176
8. L.E. Dobrunz, and C.F. Stevens Heterogeneity of release probability, facilitation, and depletion at central synapses Neuron 18 6 1997 995 1008
9. M. Dzietko, U. Felderhoff-Mueser, M. Sifringer, B. Krutz, P. Bittigau, and F. Thor Erythropoietin protects the developing brain against N-methyl-d-aspartate receptor antagonist neurotoxicity Neurobiol Dis 15 2 2004 177 187
10. D.B. Freir, C. Holscher, and C.E. Herron Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo J Neurophysiol 85 2 2001 708 713
11. M. Haghani, M. Janahmadi, and M. Shabani Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Abeta neurotoxicity Neurosci Lett 507 1 2012 33 37
12. M. Haghani, M. Shabani, M. Javan, F. Motamedi, and M. Janahmadi CB1 cannabinoid receptor activation rescues amyloid beta-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones Cell Physiol Biochem 29 3-4 2012 391 406
13. R.M. Ismailov Erythropoietin and epidemiology of Alzheimer disease Alzheimer Dis Assoc Disord 27 3 2013 204 206
14. A. Kamal, T. Al Shaibani, and G. Ramakers Erythropoietin decreases the excitatory neurotransmitter release probability and enhances synaptic plasticity in mice hippocampal slices Brain Res 1410 2011 33 37
15. M. Keller, J. Yang, E. Griesmaier, A. Gorna, G. Sarkozy, and M. Urbanek Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice Neurobiol Dis 24 2 2006 357 366
16. X. Kuang, J.R. Du, Y.S. Chen, J. Wang, and Y.N. Wang Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains Pharmacol Biochem Behav 92 4 2009 635 641
17. A. Kumral, N. Uysal, K. Tugyan, A. Sonmez, O. Yilmaz, and N. Gokmen Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia - ischemia in rats Behav Brain Res 153 1 2004 77 86
18. F. Lasne, and J. de Ceaurriz Recombinant erythropoietin in urine Nature 405 6787 2000 635
19. C. Leconte, E. Bihel, F.X. Lepelletier, V. Bouet, R. Saulnier, and E. Petit Comparison of the effects of erythropoietin and its carbamylated derivative on behaviour and hippocampal neurogenesis in mice Neuropharmacology 60 2-3 2011 354 364
20. M. Leist, P. Ghezzi, G. Grasso, R. Bianchi, P. Villa, and M. Fratelli Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 5681 2004 239 242
21. C.J. Li, M. Zhou, H.G. Li, Q. Lv, X.L. Xu, and L.J. Guo Clonidine suppresses the induction of long-term potentiation by inhibiting HCN channels at the Schaffer collateral-CA1 synapse in anesthetized adult rats Cell Mol Neurobiol 33 8 2013 1075 1086
22. K. Maiese, Z.Z. Chong, Y.C. Shang, and S. Wang Erythropoietin: new directions for the nervous system Int J Mol Sci 13 9 2012 11102 11129
23. A. Mammis, T.K. McIntosh, and A.H. Maniker Erythropoietin as a neuroprotective agent in traumatic brain injury review Surg Neurol 71 5 2009 527 531 [discussion 531]
24. P.K. Molsa, R.J. Marttila, and U.K. Rinne Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia Acta Neurol Scand 91 3 1995 159 164
25. T. Ohno, T. Hasegawa, T. Tsuruoka, K. Terabe, J.K. Gimzewski, and M. Aono Short-term plasticity and long-term potentiation mimicked in single inorganic synapses Nat Mater 10 8 2011 591 595
26. D. Osredkar, J.W. Sall, P.E. Bickler, and D.M. Ferriero Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke Neurobiol Dis 38 2 2010 259 265
27. I. Pedroso, M.L. Bringas, A. Aguiar, L. Morales, M. Alvarez, and P.A. Valdes Use of Cuban recombinant human erythropoietin in Parkinson's disease treatment MEDICC Rev 14 1 2012 11 17
28. S. Peng, D.J. Garzon, M. Marchese, W. Klein, S.D. Ginsberg, and B.M. Francis Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease J Neurosci 29 29 2009 9321 9329
29. J. Pozueta, R. Lefort, and M.L. Shelanski Synaptic changes in Alzheimer's disease and its models Neuroscience 251 2013 51 65
30. D. Sargin, A. El-Kordi, A. Agarwal, M. Muller, S.M. Wojcik, and I. Hassouna Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice BMC Biol 9 2011 27
31. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, and I. Smith Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat Med 14 8 2008 837 842
32. M.H. Tabert, X. Liu, R.L. Doty, M. Serby, D. Zamora, and G.H. Pelton A 10-item smell identification scale related to risk for Alzheimer's disease Ann Neurol 58 1 2005 155 160
33. C. Tackenberg, S. Grinschgl, A. Trutzel, A.C. Santuccione, M.C. Frey, and U. Konietzko NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss Cell Death Dis 4 2013 e608
34. P. Tiraboschi, L.A. Hansen, L.J. Thal, and J. Corey-Bloom The importance of neuritic plaques and tangles to the development and evolution of AD Neurology 62 11 2004 1984 1989
35. M. Van der Stelt, C. Mazzola, G. Esposito, I. Matias, S. Petrosino, and D. De Filippis Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels Cell Mol Life Sci 63 12 2006 1410 1424
36. O. Verdonck, H. Lahrech, G. Francony, O. Carle, R. Farion, and Y. Van de Looij Erythropoietin protects from post-traumatic edema in the rat brain J Cereb Blood Flow Metab 27 7 2007 1369 1376
37. B. Viviani, S. Bartesaghi, E. Corsini, P. Villa, P. Ghezzi, and A. Garau Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor J Neurochem 93 2 2005 412 421
38. Y. Xiong, A. Mahmood, Y. Zhang, Y. Meng, Z.G. Zhang, and C. Qu Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury J Neurosurg 114 2 2011 549 559
39. J.M. Zhang, M.N. Wu, J.S. Qi, and J.T. Qiao Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo Synapse 60 4 2006 307 313
40. S. Zhi-Kun, Y. Hong-Qi, W. Zhi-Quan, P. Jing, H. Zhen, and C. Sheng-Di Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3KAkt pathway Transl Neurodegener 1 1 2012 7
41. R.S. Zucker, and W.G. Regehr Short-term synaptic plasticity Annu Rev Physiol 64 2002 355 405